Literature DB >> 19017533

Interleukin-1 (IL-1): a central regulator of stress responses.

Inbal Goshen1, Raz Yirmiya.   

Abstract

Ample evidence demonstrates that the pro-inflammatory cytokine interleukin-1 (IL-1), produced following exposure to immunological and psychological challenges, plays an important role in the neuroendocrine and behavioral stress responses. Specifically, production of brain IL-1 is an important link in stress-induced activation of the hypothalamus-pituitary-adrenal axis and secretion of glucocorticoids, which mediate the effects of stress on memory functioning and neural plasticity, exerting beneficial effects at low levels and detrimental effects at high levels. Furthermore, IL-1 signaling and the resultant glucocorticoid secretion mediate the development of depressive symptoms associated with exposure to acute and chronic stressors, at least partly via suppression of hippocampal neurogenesis. These findings indicate that whereas under some physiological conditions low levels of IL-1 promote the adaptive stress responses necessary for efficient coping, under severe and chronic stress conditions blockade of IL-1 signaling can be used as a preventive and therapeutic procedure for alleviating stress-associated neuropathology and psychopathology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19017533     DOI: 10.1016/j.yfrne.2008.10.001

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  132 in total

1.  The GLP-1 analog, liraglutide prevents the increase of proinflammatory mediators in the hippocampus of male rat pups submitted to maternal perinatal food restriction.

Authors:  Y Diz-Chaves; L Toba; J Fandiño; L C González-Matías; L M Garcia-Segura; F Mallo
Journal:  J Neuroinflammation       Date:  2018-12-05       Impact factor: 8.322

2.  Immune function and HPA axis activity in free-ranging rhesus macaques.

Authors:  Christy L Hoffman; James P Higham; Michael Heistermann; Christopher L Coe; Brian J Prendergast; Dario Maestripieri
Journal:  Physiol Behav       Date:  2011-05-27

Review 3.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

Review 4.  Cytokine interactions with adrenal medullary chromaffin cells.

Authors:  Shirley A Douglas; Dharshini Sreenivasan; Fiona H Carman; Stephen J Bunn
Journal:  Cell Mol Neurobiol       Date:  2010-11-19       Impact factor: 5.046

5.  The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: A role for the NLRP3 inflammasome.

Authors:  Matthew G Frank; Michael D Weber; Laura K Fonken; Sarah A Hershman; Linda R Watkins; Steven F Maier
Journal:  Brain Behav Immun       Date:  2015-10-19       Impact factor: 7.217

6.  CD8+ T cells promote cytokine responses to stress.

Authors:  Sarah M Clark; Chang Song; Xin Li; Achsah D Keegan; Leonardo H Tonelli
Journal:  Cytokine       Date:  2018-07-19       Impact factor: 3.861

7.  NFκB signaling regulates embryonic and adult neurogenesis.

Authors:  Yonggang Zhang; Wenhui Hu
Journal:  Front Biol (Beijing)       Date:  2012-08

8.  Knockdown of interleukin-1 receptor type-1 on endothelial cells attenuated stress-induced neuroinflammation and prevented anxiety-like behavior.

Authors:  Eric S Wohleb; Jenna M Patterson; Vikram Sharma; Ning Quan; Jonathan P Godbout; John F Sheridan
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

9.  Interaction of metabolic stress with chronic mild stress in altering brain cytokines and sucrose preference.

Authors:  Jennifer L Remus; Luke T Stewart; Robert M Camp; Colleen M Novak; John D Johnson
Journal:  Behav Neurosci       Date:  2015-04-27       Impact factor: 1.912

10.  Dorsal hippocampal interleukin-1 signaling mediates heroin withdrawal-enhanced fear learning.

Authors:  Shveta V Parekh; Jacqueline E Paniccia; Christina L Lebonville; Donald T Lysle
Journal:  Psychopharmacology (Berl)       Date:  2020-08-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.